To evaluate efficacy of Bacillus calmette-guerin (Bcg) in reducing the incidence & severity of Covid-19 in the high-risk population (Bric)- A Phase III, multicentric, quadruple blind randomized controlled trial

Accessibility Controls

Principal Investigator

Prof. S. Sinha All India Institute of Medical Sciences Delhi

Indian Council of Medical Research (ICMR)

Area of Research

Medical Sciences

Focus Area

Task Force (TF)

Start Date

2020

End Date

2021

Duration

Status

Completed

No. of Research Paper

Technologies (If Any)

No. of PhD Produced

Publications

No. of Patents

Filed : 00

Grant : 00

Accessibility Controls